The use of terlipressin in a 14-year-old adolescent with catecholamine-resistant shock after severe traumatic brain injury [6]

Acta Anaesthesiologica Scandinavica

Volumn 51, Issue 7, 2007, Pages 957-

  Meyer, S ^a   Gottschling, S ^b   Gortner, L ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; NORADRENALIN; TERLIPRESSIN;

ARTERIAL PRESSURE; BRAIN PERFUSION; CASE REPORT; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFECT; HUMAN; LETTER; PRIORITY JOURNAL; SCHOOL CHILD; TRAUMATIC BRAIN INJURY;

ADULT; ARGININE VASOPRESSIN; BLOOD PRESSURE; BRAIN INJURIES; CATECHOLAMINES; CEREBROVASCULAR CIRCULATION; DRUG RESISTANCE; HUMANS; LYSINE VASOPRESSIN; MALE; SHOCK; VASOCONSTRICTOR AGENTS;

EID: 34447321030     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01357.x     Document Type: Letter

References (4)

1. Salluh JI, Martins GA, Santino MS, Araujo LV, Verdeal JC. Early use of terlipressin in catecholamine-reistant shock improves cerebral perfusion pressure in severe traumatic brain injury. Acta Anaesthesiol Scand 2007 51 : 505 8.
2. Matok I, Vardi A, Augarten A et al. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resusCitation. A case series. Crit Care Med 2007 35 : 161 164.
3. Berg RA. A long-acting vasopressin analog for septic shock: Brilliant idea or dangerous folly? Pediatr Crit Care Med 2004 5 : 188 9.
4. Meyer S, Gottschling S, Baghai A, Wurm D, Gortner L. Arginine-vasopressin in catecholamine-refractory septic and non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 2006 10 : R71 6.